Evidence map›Paper›PMID 42943487›Full record

ReviewMicroorganisms2026

Immunomodulatory and Metabolic Effects of Ginsenosides Rg1/Rb1 in IBD, RA, and MASLD: Targeting Gut Microbiota-Autoimmunity Axis.

Xin Mao, Zongxin Shao, Min Gao, Weichen Wang, Yichen Jiang, Wenzhe Si, Yanyan Shi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin MaoResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Zongxin ShaoResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Min GaoResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Weichen WangResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Yichen JiangResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Wenzhe SiDepartment of Laboratory Medicine, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides of National Health Commission, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0003-1573-9337
Yanyan ShiResearch Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0003-0247-371X

Funding

Beijing Natural Science Foundation of China J230002Peking University Third Hospital Fund for Interdisciplinary Research BYSYJC2025060
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gastrointestinal microbiomeginsenosidesimmune system diseasesmetabolic diseasesnetwork pharmacologypolypharmacology

Identifiers

PMID42943487
PMCPMC13707669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.